ROCK2 and triple-negative breast carcinoma: FS-115 also efficiently inhibited PRK2 (protein kinase C-related protein kinase-2) and ROCK-II (Rho-associated protein kinase II) (Fig. 1D and E), both previously implicated in triple negative breast cancer growth and invasion [34,35].